Neumora Therapeutics Inc
NMRA1.650USD
+0.090+5.77%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.650USD+1.650After-hours (ET)
266.88MMarket Cap
LossP/E TTM
Neumora Therapeutics Inc
1.650
+0.090+5.77%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
Operating expenses
18.08%70.94M
25.59%62.92M
34.79%76.65M
51.73%63.82M
53.38%60.07M
--50.10M
--56.86M
34.32%42.06M
29.54%39.17M
82.06%31.31M
95.77%30.24M
74.04%26.55M
--21.13M
--17.20M
--15.45M
--15.25M
R&D expenses
13.97%52.15M
18.14%45.91M
45.74%60.63M
48.40%48.63M
55.19%45.76M
--38.86M
--41.60M
39.28%32.77M
33.12%29.48M
115.97%23.53M
92.55%22.15M
72.56%18.91M
--14.47M
--10.89M
--11.50M
--10.96M
Depreciation, depletion, and amortization
-0.63%157.00K
-5.42%157.00K
-9.83%156.00K
-6.43%160.00K
0.00%158.00K
--166.00K
--173.00K
11.04%171.00K
7.48%158.00K
23.20%154.00K
11.36%147.00K
107.94%131.00K
--150.00K
--125.00K
--132.00K
--63.00K
Operating profit
-18.08%-70.94M
-25.59%-62.92M
-34.79%-76.65M
-51.73%-63.82M
-53.38%-60.07M
---50.10M
---56.86M
-34.32%-42.06M
-29.54%-39.17M
-82.06%-31.31M
-95.77%-30.24M
-74.04%-26.55M
---21.13M
---17.20M
---15.45M
---15.25M
Net non-operating interest income (expenses)
Non-operating interest income
-51.70%3.07M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
78.34%6.37M
--5.65M
--3.84M
353.83%3.56M
4050.00%3.57M
--784.00K
--86.00K
----
----
--0.00
--0.00
----
Special income (expenses)
----
----
----
----
----
---63.90M
--0.00
--0.00
100.00%0.00
--0.00
---13.00M
100.00%0.00
---157.00M
--0.00
--0.00
---4.28M
Other non-operating income (expenses)
-108.33%-25.00K
114.42%15.00K
-5600.00%-57.00K
38.46%-24.00K
53.85%-12.00K
---104.00K
---1.00K
-124.68%-39.00K
-124.07%-26.00K
-16.40%158.00K
-23.40%108.00K
10.21%-422.00K
--103.00K
--189.00K
--141.00K
---470.00K
Income before tax
-26.37%-67.89M
45.77%-58.82M
-36.71%-72.49M
-51.97%-58.58M
-50.80%-53.72M
---108.46M
---53.03M
-26.90%-38.54M
17.23%-35.63M
-78.54%-30.37M
-181.25%-43.04M
-34.86%-26.97M
---178.03M
---17.01M
---15.30M
---20.00M
Income tax
--105.00K
-100.00%0.00
--53.00K
--125.00K
----
--268.00K
----
----
----
----
----
----
----
----
----
----
Income after tax
-26.57%-67.99M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.70M
-50.80%-53.72M
---108.73M
---53.03M
-26.90%-38.54M
17.23%-35.63M
-78.54%-30.37M
-181.25%-43.04M
-34.86%-26.97M
---178.03M
---17.01M
---15.30M
---20.00M
Net income from continuous operations
-26.57%-67.99M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.70M
-50.80%-53.72M
---108.73M
---53.03M
-26.90%-38.54M
17.23%-35.63M
-78.54%-30.37M
-181.25%-43.04M
-34.86%-26.97M
---178.03M
---17.01M
---15.30M
---20.00M
Net income attributable to controlling interests
-26.57%-67.99M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.70M
-50.80%-53.72M
---108.73M
---53.03M
-26.90%-38.54M
17.23%-35.63M
-78.54%-30.37M
-181.25%-43.04M
-34.86%-26.97M
---178.03M
---17.01M
---15.30M
---20.00M
Net income attributable to common shareholders
-26.57%-67.99M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.70M
-50.80%-53.72M
---108.73M
---53.03M
-26.90%-38.54M
17.23%-35.63M
-78.54%-30.37M
-181.25%-43.04M
-34.86%-26.97M
---178.03M
---17.01M
---15.30M
---20.00M
Basic earnings per share
-23.81%-0.42
39.69%-0.37
-30.91%-0.45
-45.56%-0.37
-45.08%-0.34
---0.61
---0.35
-26.91%-0.25
17.23%-0.23
-78.54%-0.20
-181.25%-0.28
-34.86%-0.18
---1.17
---0.11
---0.10
---0.13
Diluted earnings per share
-23.81%-0.42
39.69%-0.37
-30.91%-0.45
-45.56%-0.37
-45.08%-0.34
---0.61
---0.35
-26.91%-0.25
17.23%-0.23
-78.54%-0.20
-181.25%-0.28
-34.86%-0.18
---1.17
---0.11
---0.10
---0.13
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
